Quercetin (dietary supplement) ( DrugBank: Quercetin )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 285 | ファンコニ貧血 | 2 |
285. ファンコニ貧血
臨床試験数 : 59 / 薬物数 : 118 - (DrugBank : 32) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 155
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03476330 (ClinicalTrials.gov) | May 8, 2018 | 19/3/2018 | Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia | Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia | Fanconi Anemia;Squamous Cell Carcinoma | Drug: Quercetin (dietary supplement) | Children's Hospital Medical Center, Cincinnati | NULL | Recruiting | 2 Years | N/A | All | 55 | Phase 2 | United States |
| 2 | NCT01720147 (ClinicalTrials.gov) | July 2012 | 25/7/2012 | Quercetin in Children With Fanconi Anemia; a Pilot Study | Quercetin in Children With Fanconi Anemia; a Pilot Study | Fanconi Anemia | Drug: Quercetin (dietary supplement) | Children's Hospital Medical Center, Cincinnati | Food and Drug Administration (FDA) | Recruiting | N/A | N/A | All | 32 | Phase 1 | United States |